Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease
- PMID: 17947327
- PMCID: PMC2190704
- DOI: 10.1093/nar/gkm821
Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease
Abstract
Increasing evidence supports a role for oxidative DNA damage in aging and several neurodegenerative diseases including Alzheimer's disease (AD). Attack of DNA by reactive oxygen species (ROS), particularly hydroxyl radicals, can lead to strand breaks, DNA-DNA and DNA-protein cross-linking, and formation of at least 20 modified bases adducts. In addition, alpha,beta-unsaturated aldehydic by-products of lipid peroxidation including 4-hydroxynonenal and acrolein can interact with DNA bases leading to the formation of bulky exocyclic adducts. Modification of DNA bases by direct interaction with ROS or aldehydes can lead to mutations and altered protein synthesis. Several studies of DNA base adducts in late-stage AD (LAD) brain show elevations of 8-hydroxyguanine (8-OHG), 8-hydroxyadenine (8-OHA), 5-hydroxycytosine (5-OHC), and 5-hydroxyuracil, a chemical degradation product of cytosine, in both nuclear and mitochondrial DNA (mtDNA) isolated from vulnerable regions of LAD brain compared to age-matched normal control subjects. Previous studies also show elevations of acrolein/guanine adducts in the hippocampus of LAD subjects compared to age-matched controls. In addition, studies of base excision repair show a decline in repair of 8-OHG in vulnerable regions of LAD brain. Our recent studies show elevated 8-OHG, 8-OHA, and 5,6-diamino-5-formamidopyrimidine in both nuclear and mtDNA isolated from vulnerable brain regions in amnestic mild cognitive impairment, the earliest clinical manifestation of AD, suggesting that oxidative DNA damage is an early event in AD and is not merely a secondary phenomenon.
Figures
Similar articles
-
DNA oxidation in Alzheimer's disease.Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2039-45. doi: 10.1089/ars.2006.8.2039. Antioxid Redox Signal. 2006. PMID: 17034348 Review.
-
Increased nuclear DNA oxidation in the brain in Alzheimer's disease.J Neurochem. 1998 Nov;71(5):2034-40. doi: 10.1046/j.1471-4159.1998.71052034.x. J Neurochem. 1998. PMID: 9798928
-
Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment.J Neurochem. 2006 Feb;96(3):825-32. doi: 10.1111/j.1471-4159.2005.03615.x. Epub 2006 Jan 9. J Neurochem. 2006. PMID: 16405502
-
Oxidatively modified RNA in mild cognitive impairment.Neurobiol Dis. 2008 Feb;29(2):169-75. doi: 10.1016/j.nbd.2007.07.030. Epub 2007 Sep 1. Neurobiol Dis. 2008. PMID: 17920285 Free PMC article.
-
Oxidative damage in mild cognitive impairment and early Alzheimer's disease.J Neurosci Res. 2007 Nov 1;85(14):3036-40. doi: 10.1002/jnr.21346. J Neurosci Res. 2007. PMID: 17510979 Review.
Cited by
-
MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders.Curr Genomics. 2009 May;10(3):154-68. doi: 10.2174/138920209788185252. Curr Genomics. 2009. PMID: 19881909 Free PMC article.
-
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.Acta Pharm Sin B. 2022 Feb;12(2):511-531. doi: 10.1016/j.apsb.2021.06.014. Epub 2021 Jun 30. Acta Pharm Sin B. 2022. PMID: 35256932 Free PMC article. Review.
-
Neurobiology of the aging dog.Age (Dordr). 2011 Sep;33(3):485-96. doi: 10.1007/s11357-010-9183-3. Epub 2010 Sep 16. Age (Dordr). 2011. PMID: 20845082 Free PMC article.
-
Natural antioxidants that act against Alzheimer's disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action.Front Endocrinol (Lausanne). 2023 Jul 3;14:1217730. doi: 10.3389/fendo.2023.1217730. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37465125 Free PMC article. Review.
-
Neurodegeneration and ageing in the HAART era.J Neuroimmune Pharmacol. 2009 Jun;4(2):163-74. doi: 10.1007/s11481-008-9143-1. Epub 2008 Dec 6. J Neuroimmune Pharmacol. 2009. PMID: 19067177 Review.
References
-
- Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262:2551–2556. - PubMed
-
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 2003;60:1119–1122. - PubMed
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. 4th. Washington, DC: American Psychiatric Publishing; 2000.
-
- National Institute on Aging and Reagan Institute. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging. 1997;18(Suppl. 4):S1–S2. - PubMed
-
- Jost BC, Grossberg GT. The natural history of Alzheimer's disease: a brain bank study. J. Am. Geriatr. Soc. 1995;43:1248–1255. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical